Treating Acute Leukemias
in Europe
Bridging Science and Practice: From Newest Clinical Approaches to Real-World Clinical Cases
Overview
This 2-day virtual program offers a comprehensive overview of the latest clinical updates and novel treatment strategies for acute leukemia, presented by experts. Attendees will have the opportunity to gain knowledge on optimal treatment of patients with leukemia, join patient case-based discussions, and interact with experts.
Date and Location
November 16-17, 2023, Webinar
Meeting Content
View the slides and watch the video of Day 1
Virtual Plenary Sessions
View the slides and watch the video of Day 2
Virtual Breakout: Adult ALL Patients
View the slides and watch the video of Day 2
Virtual Breakout: Pediatric ALL Patients
View the slides and watch the video of Day 2
Virtual Breakout: Adult AML Patients
Ask your questions directly to the experts and receive their personal insights on current and novel treatment approaches for pediatric and adult patients with acute leukemias.
Co-Chairs
Elias Jabbour, MD
MD Anderson Cancer Center, Houston, TX, USA
Naval Daver, MD
MD Anderson Cancer Center, Houston, TX, USA
Faculty
Will be announced soon
Faculty
Josep-Maria Ribera, MD, PhD
Catalan Institute of Oncology, University Hospital Germans Trias i Pujol,
Spain
Agnieszka Wierzbowska, MD, PhD
Medical University of Lodz,
Poland
Rob Pieters, MD, PhD
Princess Máxima Center for Pediatric Oncology, University of Utrecht,
The Netherlands
Nicola Gökbuget, MD
University Hospital Frankfurt, Germany
Christina Peters, MD
St. Anna Children’s Hospital, Austria
Nicolas Boissel, MD, PhD
Hôpital Saint-Louis, France
|
Agenda |
This 2-day interactive virtual meeting with global experts will focus on the treatment of patients with acute leukemia in various countries within Europe. Day 1: Follow interactive presentations and case-based discussions on the latest updates for ALL and AML, including the role of MRD, risk stratification, and long-term safety considerations, and engage with the faculty in panel discussions on optimal treatment, patient access, and regional challenges across Europe. Day 2: Join to learn more about current approaches for relapsed ALL and AML, considerations for AYA ALL management (including case-based discussions), the evolving role of transplantation, and interact with faculty during a panel discussion on how first-line therapy influences subsequent treatment. |
Day 1: Plenary Sessions
Thursday, November 16, 2023
18.00 – 21.00 (UTC +1) Amsterdam
Agenda will be announced soon
Day 2: Plenary Sessions
Friday, November 17, 2023
18.00 – 21.15 (UTC +1) Amsterdam
Agenda will be announced soon
